Johnson & Johnson MedTech launches new 2D ICE catheter

Michael Walter | May 21, 2025 | Cardiovascular Business | Electrophysiology

SoundStar Crystal Ultrasound Catheter Johnson & Johnson MedTech

Johnson & Johnson MedTech has officially launched a new 2D intracardiac echocardiography (ICE) catheter to be used during cardiac ablation procedures.

The SoundStar Crystal Ultrasound Catheter was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists. It features an 88-element phased linear array and is integrated with the company’s Carto 3 Mapping System. Carto 3 integration gives users access to artificial intelligence features such as automatic left atrial anatomy generation.

“We are proud to advance our legacy in integrated ultrasound catheters with this latest innovation that equips electrophysiologists with the tools they need to promote patient safety and drive effective results,” Jasmina Brooks, president of electrophysiology for Johnson & Johnson MedTech, said in a prepared statement. “The superior image quality, improved catheter maneuverability and stability of the SoundStar ultrasound catheter, along with seamless Carto 3 system integration, can help enable a zero-fluoroscopy workflow, enhancing procedure effectiveness and safety for both healthcare professionals and patients they treat.”

“During the cases I performed with the SoundStar Crystal Ultrasound Catheter, I was impressed by the clear visualization, tissue definition and enhanced far field imaging, and full integration with other platforms. Integration with the Carto 3 System provides clear, high-resolution images which simplify the anatomical mapping process and procedure workflow,” added Amin Al-Ahmad, MD, an electrophysiologist with St. David’s HealthCare in Austin, Texas.

The SoundStar Crystal ultrasound catheter was developed and manufactured by Johnson & Johnson MedTech’s Biosense Webster division. In September 2024, the company announced that Biosense Webster, Abiomed, Cerenovus and some of its other known healthcare technology companies would now go by the name Johnson & Johnson MedTech going forward.

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

PFA associated with elevated risk of heart damage, real-world data show

PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data

Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business

U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.